Global disruption of cell cycle progression and nutrient response by the antifungal agent amiodarone

Yong-Qiang Zhang1, Rajini Rao

  • 1Department of Physiology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Insights

The antiarrhythmic drug amiodarone exhibits fungicidal properties by disrupting calcium signaling and nutrient sensing pathways in yeast. This leads to cell death and suggests a novel antifungal mechanism distinct from existing treatments.

Area of Science:

  • Mycology
  • Molecular Biology
  • Pharmacology

Background:

  • Amiodarone, an antiarrhythmic drug, possesses broad-spectrum fungicidal activity.
  • Its mechanism of action against fungi, particularly Saccharomyces cerevisiae, involves calcium influx and mitochondrial fragmentation.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying amiodarone's antifungal toxicity.
  • To analyze the transcriptional response of Saccharomyces cerevisiae to amiodarone exposure.

Main Methods:

  • DNA microarray analysis was employed to assess the transcriptional response of S. cerevisiae to amiodarone.
  • Gene expression patterns were compared with responses to calcium chloride (CaCl(2)) and other cellular stress conditions.

Main Results:

  • Amiodarone induced a rapid calcium influx and nuclear accumulation of calcineurin-regulated Crz1.
  • Upregulated genes were associated with nutrient utilization and energy mobilization, resembling starvation responses.
  • Downregulated genes were involved in cell cycle control, with temporary delays observed in G(1), S, and G(2)/M phases.
  • A subset of nutrient-responsive genes were affected by amiodarone independently of calcium.

Conclusions:

  • Amiodarone's antifungal toxicity involves interference with nutrient sensing and regulatory networks, independent of its calcium-mediated effects.
  • The drug impacts cell cycle progression in a calcineurin-dependent manner.
  • Transcriptional responses to amiodarone are distinct from other antifungal classes, suggesting a novel therapeutic pathway for fungal infections.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...